{"nct_id":"NCT00447226","title":"Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists","status":"TERMINATED","status_verified_date":"2012-06","start_date":"2007-05","start_date_type":null,"primary_completion_date":"2009-05","primary_completion_date_type":"ACTUAL","completion_date":"2009-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}